{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T07:43:04Z","timestamp":1777016584017,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["P2022\/BMD7212"],"award-info":[{"award-number":["P2022\/BMD7212"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PID2023-151128OB-I00\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["PID2023-151128OB-I00\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["PID2019\\u2013104867RB-I00\/AEI\/10.13039\/501100011033"],"award-info":[{"award-number":["PID2019\\u2013104867RB-I00\/AEI\/10.13039\/501100011033"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["RTI2018\\u2013099343-B-100"],"award-info":[{"award-number":["RTI2018\\u2013099343-B-100"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["CB16\/12\/00326"],"award-info":[{"award-number":["CB16\/12\/00326"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014139","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","doi-asserted-by":"publisher","award":["AESI 2024 PI24CIII\/00046"],"award-info":[{"award-number":["AESI 2024 PI24CIII\/00046"]}],"id":[{"id":"10.13039\/501100014139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Gobierno de Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002704","name":"Fundaci\u00f3n Cient\u00edfica Asociaci\u00f3n Espa\u00f1ola Contra el C\u00e1ncer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.biopha.2025.118873","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T02:26:53Z","timestamp":1765333613000},"page":"118873","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeted radioiodine therapy of ovarian cancer via the sodium\/iodide symporter (NIS)"],"prefix":"10.1016","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3205-7277","authenticated-orcid":false,"given":"Lidia Mirela","family":"Mielu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc\u00eda","family":"Rodal-Bravo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7869-5306","authenticated-orcid":false,"given":"Cristina","family":"Diego-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2245-210X","authenticated-orcid":false,"given":"Sarai","family":"Varona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e1nae","family":"Fajardo-Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Hortiguela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1564-0671","authenticated-orcid":false,"given":"Monica","family":"Torres-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7911-9041","authenticated-orcid":false,"given":"Isabel","family":"Cuesta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Pallares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Santisteban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Custodia","family":"Garc\u00eda-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2890-7846","authenticated-orcid":false,"given":"Pilar","family":"Mart\u00edn-Duque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1187-1907","authenticated-orcid":false,"given":"Antonio","family":"De la Vieja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118873_bib1","first-page":"7","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biopha.2025.118873_bib2","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biopha.2025.118873_bib3","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/PAT.0b013e328348a6e7","article-title":"Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis","volume":"43","author":"McCluggage","year":"2011","journal-title":"Pathology"},{"key":"10.1016\/j.biopha.2025.118873_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","article-title":"TA. Epidemiology of ovarian cancer: a review","volume":"14","author":"Permuth","year":"2017","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.biopha.2025.118873_bib5","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0140-6736(13)62146-7","article-title":"Ovarian cancer","volume":"384","author":"Jayson","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2025.118873_bib6","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1200\/JCO.2008.19.1684","article-title":"Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup","volume":"27","author":"Bookman","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2025.118873_bib7","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","article-title":"Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study","volume":"21","author":"Ozols","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.biopha.2025.118873_bib8","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1470-2045(17)30279-6","article-title":"Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology\/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial","volume":"18","author":"Coleman","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biopha.2025.118873_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13048-024-01362-y","article-title":"PARP inhibitor era in ovarian cancer treatment: a systematic review and meta-analysis of randomized controlled trials","volume":"17","author":"Baradacs","year":"2024","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.biopha.2025.118873_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17122113","article-title":"Molecular characterization of epithelial ovarian cancer: implications for diagnosis and treatment","volume":"17","author":"Rojas","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118873_bib11","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S1470-2045(16)30108-5","article-title":"Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study","volume":"17","author":"Bagnoli","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biopha.2025.118873_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17071169","article-title":"Immune checkpoint inhibitors: a new opportunity in the treatment of ovarian cancer?","volume":"17","author":"Mittica","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118873_bib13","doi-asserted-by":"crossref","DOI":"10.1021\/acsabm.3c01064","article-title":"Recent advances in nanotechnology-based drug delivery systems for the diagnosis and treatment of reproductive disorders","author":"Acharya","year":"2024","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.biopha.2025.118873_bib14","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1152\/physrev.2000.80.3.1083","article-title":"Molecular analysis of the sodium\/iodide symporter: impact on thyroid and extrathyroid pathophysiology","volume":"80","author":"De La Vieja","year":"2000","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.biopha.2025.118873_bib15","doi-asserted-by":"crossref","first-page":"T121","DOI":"10.1530\/ERC-21-0037","article-title":"Radioiodine treatment: an historical and future perspective","volume":"28","author":"Borges de Souza","year":"2021","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.biopha.2025.118873_bib16","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.7150\/thno.24997","article-title":"18)F]Tetrafluoroborate ([(18)F]TFB) and its analogs for PET imaging of the sodium\/iodide symporter","volume":"8","author":"Jiang","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2025.118873_bib17","doi-asserted-by":"crossref","first-page":"R225","DOI":"10.1530\/ERC-17-0515","article-title":"Role of iodide metabolism in physiology and cancer","volume":"25","author":"De la Vieja","year":"2018","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.biopha.2025.118873_bib18","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.7150\/thno.41489","article-title":"Effective control of tumor growth through spatial and temporal control of theranostic sodium iodide symporter (NIS) gene expression using a heat-inducible gene promoter in engineered mesenchymal stem cells","volume":"10","author":"Tutter","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2025.118873_bib19","doi-asserted-by":"crossref","first-page":"E1199","DOI":"10.1210\/jc.2013-4249","article-title":"NIS mediates iodide uptake in the female reproductive tract and is a poor prognostic factor in ovarian cancer","volume":"99","author":"Riesco-Eizaguirre","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2025.118873_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3614207","article-title":"A robust gene expression prognostic signature for overall survival in high-grade serous ovarian cancer","volume":"2019","author":"Zhao","year":"2019","journal-title":"J. Oncol."},{"key":"10.1016\/j.biopha.2025.118873_bib21","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1089\/ars.2014.6228","article-title":"Selenium increases thyroid-stimulating hormone-induced sodium\/iodide symporter expression through thioredoxin\/apurinic\/apyrimidinic endonuclease 1-dependent regulation of paired box 8 binding activity","volume":"24","author":"Leoni","year":"2016","journal-title":"Antioxid. Redox Signal"},{"key":"10.1016\/j.biopha.2025.118873_bib22","doi-asserted-by":"crossref","first-page":"T141","DOI":"10.1530\/ERC-21-0217","article-title":"The complex regulation of NIS expression and activity in thyroid and extrathyroidal tissues","volume":"28","author":"Riesco-Eizaguirre","year":"2021","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.biopha.2025.118873_bib23","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1074\/mcp.M200008-MCP200","article-title":"Discordant protein and mRNA expression in lung adenocarcinomas","volume":"1","author":"Chen","year":"2002","journal-title":"Mol. Cell Proteom."},{"key":"10.1016\/j.biopha.2025.118873_bib24","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pharmthera.2012.06.007","article-title":"The sodium iodide symporter (NIS): regulation and approaches to targeting for cancer therapeutics","volume":"135","author":"Kogai","year":"2012","journal-title":"Pharm. Ther."},{"key":"10.1016\/j.biopha.2025.118873_bib25","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1210\/jc.2002-021544","article-title":"Immunohistochemical profile of the sodium\/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections","volume":"88","author":"Wapnir","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.biopha.2025.118873_bib26","doi-asserted-by":"crossref","DOI":"10.1089\/thy.2022.0163","article-title":"Basolateral sorting of the sodium\/iodide symporter is mediated by adaptor protein 1 clathrin adaptor complexes","author":"Koumarianou","year":"2022","journal-title":"Thyroid"},{"key":"10.1016\/j.biopha.2025.118873_bib27","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1530\/ERC-21-0234","article-title":"Radioiodine: 80 years and counting; the past, present, and future","volume":"28","author":"Ringel","year":"2021","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.biopha.2025.118873_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9101406","article-title":"Cisplatin mouse models: treatment, toxicity and translatability","volume":"9","author":"Perse","year":"2021","journal-title":"Biomedicines"},{"issue":"24","key":"10.1016\/j.biopha.2025.118873_bib29","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1002\/cncr.32544","article-title":"New strategies in ovarian cancer treatment","volume":"125","author":"Lee","year":"2019","journal-title":"Cancer"},{"key":"10.1016\/j.biopha.2025.118873_bib30","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11060-009-9971-8","article-title":"Breast cancer brain metastases express the sodium iodide symporter","volume":"96","author":"Renier","year":"2010","journal-title":"J. Neurooncol"},{"key":"10.1016\/j.biopha.2025.118873_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142984","article-title":"Glycosylation of sodium\/iodide symporter (NIS) regulates its membrane translocation and radioiodine uptake","volume":"10","author":"Chung","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118873_bib32","first-page":"22657","article-title":"N-linked glycosylation of the thyroid Na+\/I- symporter (NIS)","volume":"273","author":"Levy","year":"1998","journal-title":"Implic. Second. Struct. Model. J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118873_bib33","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s10549-020-05884-z","article-title":"Development and validation of prognostic gene signature for basal-like breast cancer and high-grade serous ovarian cancer","volume":"184","author":"Zhang","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.biopha.2025.118873_bib34","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1091\/mbc.e03-05-0279","article-title":"Gene expression patterns in ovarian carcinomas","volume":"14","author":"Schaner","year":"2003","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.biopha.2025.118873_bib35","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1111\/jog.14054","article-title":"Establishment of patient-derived xenograft model in ovarian cancer and its influence factors analysis","volume":"45","author":"Wu","year":"2019","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.biopha.2025.118873_bib36","doi-asserted-by":"crossref","first-page":"8750","DOI":"10.18632\/oncotarget.2373","article-title":"Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer","volume":"5","author":"Dobbin","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2025.118873_bib37","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20180136","article-title":"Differentiated thyroid cancer theranostics: radioiodine and beyond","volume":"91","author":"Choudhury","year":"2018","journal-title":"Br. J. Radio."},{"key":"10.1016\/j.biopha.2025.118873_bib38","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1038\/sj.gt.3301558","article-title":"In vivo sodium iodide symporter gene therapy of prostate cancer","volume":"8","author":"Spitzweg","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.biopha.2025.118873_bib39","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/sj.gt.3302599","article-title":"Sodium iodide symporter-mediated radioiodide imaging and therapy of ovarian tumor xenografts in mice","volume":"13","author":"Dwyer","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.biopha.2025.118873_bib40","first-page":"117","article-title":"Cataloging antineoplastic agents according to their effectiveness against platinum-resistant and platinum-sensitive ovarian carcinoma cell lines","volume":"2","author":"Ishiguro","year":"2016","journal-title":"J. Transl. Sci."},{"key":"10.1016\/j.biopha.2025.118873_bib41","article-title":"In vivo molecular imaging and radionuclide (131I) therapy of human nasopharyngeal carcinoma cells transfected with a lentivirus expressing sodium iodide symporter","volume":"10","author":"Shi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118873_bib42","article-title":"Cisplatin-induced sudden cardiac death with hemodynamic collapse: a severe adverse drug reaction: case report","volume":"96","author":"Abramavicius","year":"2017","journal-title":"Med. (Baltim. )"},{"key":"10.1016\/j.biopha.2025.118873_bib43","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/thy.2018.0597","volume":"29","author":"Tuttle","year":"2019","journal-title":"Thyroid"},{"key":"10.1016\/j.biopha.2025.118873_bib44","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/mt.2010.296","article-title":"Epidermal growth factor receptor-targeted (131)I-therapy of liver cancer following systemic delivery of the sodium iodide symporter gene","volume":"19","author":"Klutz","year":"2011","journal-title":"Mol. Ther."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225010674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225010674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T07:04:33Z","timestamp":1777014273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225010674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":44,"alternative-id":["S0753332225010674"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118873","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted radioiodine therapy of ovarian cancer via the sodium\/iodide symporter (NIS)","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118873","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118873"}}